An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...